Registration

Speaker detail

  • Sophie Morin
  • Director Quality Planning & Strategy
  • Janssen R&D (J&J), United Kingdom

Sophie Morin has more than 18 years experience in the pharmaceutical industry. She spent most part of her career working in Quality and Compliance for Janssen R&D where she held various roles of increasing responsibilities. Sophie expertise lies with auditing, trial oversight, vendor management, Quality strategy and inspection management for GCP and Pharmacovigilance.

Currently Sophie is the Quality Planning and Strategy Head for Cardiovascular and Metabolism where she drives the strategy to provide integrated quality risk approach to the Janssen portfolio.